Yasser Bustanji, Noor Barham, Eman Y Abu-Rish, Abdelkareem Alhyari, Basil Albustanji, Majd Alnajjar, Bashaer Abu-Irmaileh, Waseem El-Huneidi, Eman Abu-Gharbieh, Mohammad Mohammad, Mohammed Fararjeh, Ala Issa, Mohammad Semreen, Hana Bajes
OBJECTIVES: We aimed to evaluate the levels of serum lipoprotein a, LP (a), in Jordanian patients with type 2 diabetes mellitus (DM); and to examine its relation to glycemic control, metabolic syndrome (MS) and duration of DM. The LP (a) is considered one of the independent risk factors for coronary artery disease (CAD) in the general population. METHODS: Fasting blood samples were drawn from 51 diabetic patients with type 2 DM and 31 non-diabetic age and sex control subjects...
September 1, 2022: Hormone Molecular Biology and Clinical Investigation